Correlation Between Toronto Dominion and Big Pharma
Can any of the company-specific risk be diversified away by investing in both Toronto Dominion and Big Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Toronto Dominion and Big Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Toronto Dominion Bank and Big Pharma Split, you can compare the effects of market volatilities on Toronto Dominion and Big Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Toronto Dominion with a short position of Big Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Toronto Dominion and Big Pharma.
Diversification Opportunities for Toronto Dominion and Big Pharma
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Toronto and Big is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Toronto Dominion Bank and Big Pharma Split in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Big Pharma Split and Toronto Dominion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Toronto Dominion Bank are associated (or correlated) with Big Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Big Pharma Split has no effect on the direction of Toronto Dominion i.e., Toronto Dominion and Big Pharma go up and down completely randomly.
Pair Corralation between Toronto Dominion and Big Pharma
Assuming the 90 days horizon Toronto Dominion Bank is expected to generate 0.51 times more return on investment than Big Pharma. However, Toronto Dominion Bank is 1.96 times less risky than Big Pharma. It trades about 0.35 of its potential returns per unit of risk. Big Pharma Split is currently generating about 0.04 per unit of risk. If you would invest 7,462 in Toronto Dominion Bank on October 9, 2024 and sell it today you would earn a total of 316.00 from holding Toronto Dominion Bank or generate 4.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Toronto Dominion Bank vs. Big Pharma Split
Performance |
| Timeline |
| Toronto Dominion Bank |
| Big Pharma Split |
Toronto Dominion and Big Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Toronto Dominion and Big Pharma
The main advantage of trading using opposite Toronto Dominion and Big Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Toronto Dominion position performs unexpectedly, Big Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Big Pharma will offset losses from the drop in Big Pharma's long position.| Toronto Dominion vs. Royal Bank of | Toronto Dominion vs. Bank of Nova | Toronto Dominion vs. Bank of Montreal | Toronto Dominion vs. Canadian Imperial Bank |
| Big Pharma vs. Sustainable Power Infrastructure | Big Pharma vs. Global Dividend Growth | Big Pharma vs. Brompton Lifeco Split | Big Pharma vs. Prime Dividend Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |